Participate in Our Long Haul Covid Human Clinical Trials - Vitti Long Haul
Vitti Long Haul is conducting Human Clinical Trials for Long Haul COVID patients. Their therapy, VL-PX10 and VL-P22, is currently in Phase 2 of the trials and concentrates on treating Pulmonary Fibrosis. The therapy blends human Umbilical Cord Mesenchymal Stem Cell Exosomes, Mesenchymal Stem Cells, and biomaterials. Contact us to learn more about our Long Haul Covid Human Clinical Trials https://vittilonghaul.com/about-us.
Like
Comment
Share
